Clinical Trial Update: OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results update for OTL38 used in intra-operative imaging of folate receptor positive ovarian cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• OTL38

Snippet

Sponsor: On Target Laboratories, LLC | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED | Results posted: 2022-02-04